Exercise and Nutritional Intervention in Older Adults With Sarcopenia (Spleen-Kidney Deficiency Pattern)
A Prospective Single-Arm Cohort Study of Exercise and Nutritional Intervention in Older Adults With Sarcopenia (Spleen-Kidney Deficiency Pattern)
This study will enroll older adults with sarcopenia (Spleen-Kidney Deficiency Pattern) who will receive exercise and nutritional interventions. By assessing changes from baseline in DXA-measured appendicular muscle mass and other efficacy outcomes, the study aims to characterize the longitudinal changes in sarcopenia over a 24-week period and provide an external control for a future randomized, double-blind clinical trial of Peiyuan Guben Tongluo Ointment in older adults with sarcopenia (Spleen-Kidney Deficiency Pattern).
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Xiao ya Zhang, Undergraduate
- Número de teléfono: +86 13645337890
- Correo electrónico: 2365672026@qq.com
Ubicaciones de estudio
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Porcelana, 200437
- Reclutamiento
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patients aged ≥ 60 and ≤ 90 years, regardless of sex.
- Meet the diagnostic criteria for sarcopenia in older adults according to both Western medicine and traditional Chinese medicine (TCM).
- Meet the TCM diagnostic criteria for the Spleen-Kidney Deficiency Pattern.
- Be willing to comply with the study intervention protocol, attend scheduled follow-up visits, and provide written informed consent.
Exclusion Criteria:
- Patients with severe cerebrovascular diseases resulting in quadriplegia, long-term bedridden status, or complete loss of muscle strength (Grade 0); patients with muscle atrophy caused by various factors; or those unable to perform activities of daily living independently.
- Patients with Alzheimer's disease or vascular dementia accompanied by impaired consciousness, aphasia, delirium, inability to communicate or respond appropriately, or disorientation to time, place, or person.
- Patients with severe psychiatric disorders or depressive conditions who are receiving relevant pharmacological treatment.
- Patients with comorbid conditions that may affect nutritional status, including malignancies, severe infections, gastrointestinal bleeding, hepatic or renal insufficiency, or cardiac insufficiency.
- Patients who have received or are currently receiving traditional Chinese medicine treatment within the past month, or who have received medications affecting muscle contraction or relaxation within the past month.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
DXA-measured appendicular skeletal muscle mass
Periodo de tiempo: Baseline, week 12, week 24
|
Detected by dual-energy X-ray absorptiometry (GE Healthcare, DXA). The skeletal muscle mass index (SMI) is defined as the ratio of DXA-measured skeletal muscle mass to the square of height. |
Baseline, week 12, week 24
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Upper limb handgrip strength
Periodo de tiempo: Up to 24 weeks
|
Use a hand dynamometer to record grip strength data for comparison. |
Up to 24 weeks
|
|
Handgrip strength
Periodo de tiempo: Baseline, week 12, week 24
|
Use a hand dynamometer to record grip strength data for comparison. |
Baseline, week 12, week 24
|
|
Timed Up and Go test (TUG)
Periodo de tiempo: Baseline, week 12, week 24
|
Subjects shall sit on a chair with a seat height of 46 cm, a straight backrest and armrests (armrest height approximately 65 cm). They are required to stand up with minimal assistance from the armrests. The total time is recorded from leaving the backrest to standing upright, walking 3 meters at their usual walking speed, turning around, walking back, and sitting down fully against the chair back. The average value of three trials is calculated. Elderly individuals who routinely use walking aids may use them during the test. |
Baseline, week 12, week 24
|
|
Berg Balance Scale (BBS)
Periodo de tiempo: Baseline, week 12, week 24
|
The scale consists of 14 items in total, including sitting to standing, standing to sitting, standing unsupported, standing with eyes closed, reaching forward with outstretched arms, turning 360 degrees, alternating foot placement on a step, single-leg standing, etc. All items take 10-15 minutes to complete. Each item is scored from a minimum of 0 points to a maximum of 4 points, with a total possible score of 56 points. A higher score indicates better balance function; a score below 40 points suggests an increased risk of falls. |
Baseline, week 12, week 24
|
|
TCM Syndrome Score
Periodo de tiempo: Baseline, week 12, week 24
|
In accordance with the scoring criteria specified in the 《Guiding Principles for Clinical Research of New Traditional Chinese Medicine Drugs》, the total score for **Spleen-Kidney Deficiency Syndrome** was calculated. |
Baseline, week 12, week 24
|
|
Mini Nutritional Assessment (MNA)
Periodo de tiempo: Baseline, week 12, week 24
|
Nutritional status was evaluated using the Mini Nutritional Assessment (MNA). This scale comprehensively evaluates an individual's nutritional status through a series of questions covering body weight, dietary intake, mobility, mental state and other aspects. The full score of the scale is 30 points. Grading criteria: a total score ≥ 24 indicates good nutritional status; a score between 17 and 24 suggests risk of malnutrition; a total score below 17 confirms definite malnutrition. |
Baseline, week 12, week 24
|
|
Activities of Daily Living (ADL) Scale
Periodo de tiempo: Baseline. week 12, week 24
|
The Activities of Daily Living (ADL) scale, developed by American scholars Lawton and Brody in 1969, is a medical assessment tool composed of the Physical Self-Maintenance Scale (PSMS) and the Instrumental Activities of Daily Living (IADL). It is mainly used to evaluate subjects' functional levels in basic living skills such as feeding, dressing and mobility, as well as the ability to use instrumental tools. Constructed from two dimensions including PSMS and IADL, the scale contains a total of 10 assessment items. |
Baseline. week 12, week 24
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Fenghua Qian, Undergraduate, Shanghai Yueyang Integrated Medicine Hospital
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- YY-PYGBTLG-002
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .